These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 230056)
1. Effects of progesterone and R2323 on the development of dimethylbenzanthracene-induced mammary tumors. Kelly PA; Asselin J; Turcot-Lemay L; Labrie F; Raynaud JP Eur J Cancer (1965); 1979 Oct; 15(10):1243-51. PubMed ID: 230056 [No Abstract] [Full Text] [Related]
2. Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. Asselin J; Labrie F J Steroid Biochem; 1978 Nov; 9(11):1079-82. PubMed ID: 106188 [No Abstract] [Full Text] [Related]
3. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat. Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985 [TBL] [Abstract][Full Text] [Related]
5. Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Arafah BM; Manni A; Pearson OH Endocrinology; 1980 Nov; 107(5):1364-9. PubMed ID: 6253265 [No Abstract] [Full Text] [Related]
6. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300 [TBL] [Abstract][Full Text] [Related]
7. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors. Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338 [TBL] [Abstract][Full Text] [Related]
8. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma. Labrie F; Kelly PA; Asselin J; Raynaud JP Recent Results Cancer Res; 1976; (57):109-20. PubMed ID: 827798 [TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone receptor levels in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in each week--check points about experimental studies using DMBA-induced tumors. Iino Y; Izuo M; Horiuchi R Jpn J Exp Med; 1990 Dec; 60(6):351-4. PubMed ID: 2128946 [No Abstract] [Full Text] [Related]
10. Influence of 1 alpha,25-dihydroxyvitamin D3 on the development and steroid hormone receptor contents of DMBA-induced rat mammary tumors. Noguchi S; Tahara H; Miyauchi K; Koyama H Oncology; 1989; 46(4):273-6. PubMed ID: 2500626 [TBL] [Abstract][Full Text] [Related]
11. Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Asselin J; Kelly PA; Caron MG; Labrie F Endocrinology; 1977 Sep; 101(3):666-71. PubMed ID: 196828 [No Abstract] [Full Text] [Related]
12. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors. Turcot-Lemay L; Kelly PA Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058 [No Abstract] [Full Text] [Related]
13. Progesterone and progesterone receptors in experimental breast cancer. Horwitz KB; McGuire WL Cancer Res; 1977 Jun; 37(6):1733-8. PubMed ID: 404036 [No Abstract] [Full Text] [Related]
14. Prolactin receptors in primary cultures of carcinogen-induced rat-mammary tumors. Costlow ME; Gallagher PE; Koseki Y Mol Cell Endocrinol; 1979 Apr; 14(1):81-97. PubMed ID: 222641 [TBL] [Abstract][Full Text] [Related]
15. Gestrinone (R2323) binding to steroid receptors in human uterine endometrial cytosol. Tamaya T; Fujimoto J; Watanabe Y; Arahori K; Okada H Acta Obstet Gynecol Scand; 1986; 65(5):439-41. PubMed ID: 3490730 [TBL] [Abstract][Full Text] [Related]
16. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats. Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050 [TBL] [Abstract][Full Text] [Related]
17. Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors. Asselin J; Labrie F; Kelly PA; Philibert D; Raynaud JP Steroids; 1976 Mar; 27(3):395-404. PubMed ID: 178076 [TBL] [Abstract][Full Text] [Related]
18. Establishment of pharmacological doses of estrogen-dependent mammary tumors with estrogen and progesterone receptors. Yoshida H; Yoshida A; Noguchi S; Matsumoto K In Vivo; 1987; 1(3):157-61. PubMed ID: 2979780 [TBL] [Abstract][Full Text] [Related]
19. Lack of relationship between prolactin binding and growth rate of carcinogen-induced mammary tumors or circulating levels of mammotropic hormones in rats. Nagasawa H; Yanai R; Shiota K; Nakajima Y Gan; 1980 Apr; 71(2):271-2. PubMed ID: 6259012 [No Abstract] [Full Text] [Related]
20. Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model. Jordan VC; Allen KE Eur J Cancer (1965); 1980 Feb; 16(2):239-51. PubMed ID: 6768559 [No Abstract] [Full Text] [Related] [Next] [New Search]